Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) EBT Margin (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of EBT Margin data on record, last reported at 18325.64% in Q3 2020.

  • For Q3 2020, EBT Margin fell 1714868.0% year-over-year to 18325.64%; the TTM value through Jun 2021 reached 31541.03%, down 3144383.0%, while the annual FY2025 figure was 10507.38%, N/A changed from the prior year.
  • EBT Margin reached 18325.64% in Q3 2020 per COGT's latest filing, down from 1401.52% in the prior quarter.
  • Across five years, EBT Margin topped out at 15.05% in Q4 2019 and bottomed at 18325.64% in Q3 2020.
  • Average EBT Margin over 3 years is 2116.33%, with a median of 382.93% recorded in 2019.
  • The widest YoY moves for EBT Margin: up 29626bps in 2020, down -1714868bps in 2020.
  • A 3-year view of EBT Margin shows it stood at 225.91% in 2018, then surged by 107bps to 15.05% in 2019, then crashed by -121857bps to 18325.64% in 2020.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 18325.64% in Q3 2020, 1401.52% in Q2 2020, and 86.67% in Q1 2020.